Articles

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Hospital Universitario Central de Asturias, Oviedo, Spain
Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Hospital Universitario de Salamanca, Salamanca, Spain
Hospital Clínico Universitario-INCLIVA, Valencia, Spain
Hospital Son Dureta, Palma de Mallorca, Spain
Catalan Institute of Oncology-Idibell, L’Hospitalet de Llobregat, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Ramón y Cajal, Madrid, Spain
Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
ERESA, Valencia, Spain
Novartis Farmacéutica S.A., Barcelona, Spain
Hospital Universitario La Fe, Valencia, Spain
Vol. 99 No. 10 (2014): October, 2014 https://doi.org/10.3324/haematol.2014.105908